| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $455.5M | — | +82.8% |
| Cost of Revenue | $368.2M | — | +87.9% |
| Gross Profit | $87.4M | — | +63.9% |
| R&D Expense | $6.7M | — | +44.8% |
| SG&A Expense | $58.5M | — | +90.6% |
| Operating Income | $15.4M | — | +6.8% |
| Pre-tax Income | $1.2M | — | -59.3% |
| Income Tax | $488K | — | -38.0% |
| Net Income | $695K | — | -66.5% |
| EPS (Basic) | $0.01 | — | -97.4% |
| EPS (Diluted) | $0.01 | — | -97.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115.9M | +17.6% | +142.3% |
| Accounts Receivable | $271.2M | -12.7% | +62.2% |
| Inventory | $379.2M | +9.5% | +45.6% |
| Current Assets | $890.3M | +1.4% | +66.0% |
| Total Assets | $2.01B | -0.1% | +79.7% |
| Current Liabilities | $448.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.7M | — | +33.2% |
| Capital Expenditures | $1.9M | — | -37.8% |
| Investing Cash Flow | -$1.1M | — | +66.1% |
| Financing Cash Flow | $36.8M | — | +221.9% |
| Free Cash Flow | -$19.7M | — | +33.7% |
| +73.7% |
| Long-term Debt | $628.9M | +5.7% | +56.3% |
| Total Liabilities | $1.19B | -0.1% | +59.9% |
| Stockholders' Equity | $814.7M | -0.0% | +119.4% |